Pentadecapeptide BPC 157, composed of 15 amino acids, is a partial sequence of body protection compound (BPC) that is discovered in and isolated from human gastric juice. Experimentally it has been demonstrated to accelerate the healing of many different wounds, including tendon-to-bone healing and superior healing of damaged ligaments. In addition, BPC 157 seems to protect organs and to prevent ulcers of the stomach. This peptide is also shown to decrease pain in damaged areas. Those who su er from discomfort due to muscle sprains, tears and damage may benefit from treatment with this peptide. It can also help aid skin burns to heal at a faster rate and increase blood flow to damaged tissues.
A full copy of all trials are available from Peptides Online. Please contact us for more information.
The promoting e ect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration Chung-Hsun Chang, Wen-Chung Tsai2 Miao-Sui Lin, Ya-Hui Hsu, and Jong-Hwei Su Pang
Many growth factors such as epidermal growth factor (EGF), transforming growth factor- (TGF-), and bone morphogenetic proteins (BMPs) have been used to improve the healing of torn tendon in the lab (2, 31). However, the short duration of these easily digested growth factors hampers their clinical usage. Gastric pentadecapeptide BPC 157 is a partial sequence of human gastric protein BPC, which has been discovered in and isolated from gastric juice (5). It is highly stable and resistant to hydrolysis or enzyme digestion, even in the gastric juice. Besides, it is easily dissolved in water and needs no carrier for its application. Experimentally it was demonstrated to enhance the healing of di erent wounds, such as gastric ulcer (19, 32), skin (4, 15), cornea (13), muscle (28), colon-colon anastomosis (22), colocutaneous fistula (11), and segmental bone defect (21). It was also found to accelerate the healing of transected rat Achilles tendon (12, 29) and medial collateral ligament of knee (8). Currently it is in clinical trial for treating inflammatory bowel disease.
- Content and Potency: 5mL x 2 vial 2000mcg/ml ready to inject subcutaneously.
- Suggested dosage: Inject 0.1ml (10 units) injected subcutaneously every day for 7 weeks.
Please note, as this is a prescription item, one of our doctors will review your profile and approve your order if appropriate. A prescription will only be issued in accordance to the prescribing guidelines, and for use that strictly complies to the doctor’s directions and dosage. This script will be forwarded to our dispensary team, and placed in our secure, internal records.